Clinical Resources

Potential stem cell-derived therapies are advancing from the laboratory towards the clinic. These cell-based approaches present novel considerations for clinicians and the public alike. The ISSCR is dedicated to helping educate and inform clinicians, review boards, and the public with current, scientifically-grounded information on these advances and their application(s).




Guidelines that outline core principles of scientific rigor and research integrity, regularly updated based on scientific developments and disseminated to researchers, clinicians, organizations and institutions around the world.


Remembering Eli Broad

  • 4 May, 2021
Eli Broad headshot

The ISSCR is saddened to learn of the death of Eli Broad, a philanthropist who greatly influenced the field of stem cell science. Together, Eli and Edythe Broad founded the Broad Foundation and made significant investments in science that underscore the belief that research has the potential to treat devastating diseases and significantly improve human health. The Broad Foundation has invested $113 million dollars to create three Broad Stem Cell Centers in California and invested more than $1 billion dollars to create and endow the Broad Institute in Cambridge, Massachusetts. “Eli Broad will be remembered as a strong supporter of science in general, and stem cell science in particular. His investments helped to make California a world leader in stem cell research and his funding has allowed thousands of scientists to do transformational work. He will be missed,” said former ISSCR President Deepak Srivastava, MD, Gladstone Institutes and University of California, San Francisco, USA. Eli and Edythe Broad were honored with the ISSCR Public Service Award in 2019 for their significant contributions to the field of stem cell research. Learn more about Eli Broad in this biography.